News for 'Safety Research'

Harsh Vardhan, Cong's Manish Tewari spar over nod to Covaxin

Harsh Vardhan, Cong's Manish Tewari spar over nod to Covaxin

Rediff.com16 Jan 2021

Senior Congress leader Manish Tewari and Union Health Minister Harsh Vardhan sparred on Twitter on Saturday with the Opposition leader raising questions over the emergency use approval given to the indigenously developed vaccine Covaxin and the Bharatiya Janata Party leader hitting back alleging that Tewari was only passionate about spreading rumours.

9 Tips For HEALTHIER LUNGS

9 Tips For HEALTHIER LUNGS

Rediff.com15 Nov 2021

Breathing exercises can clean your lungs, strengthen, improve lung function and increase lung capacity.

HR GURU: 'I have to sack my friend'

HR GURU: 'I have to sack my friend'

Rediff.com3 Jun 2022

HR Guru Mayank Rautela offers practical advice.

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Rediff.com11 Apr 2021

These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.

Of course, you will watch a movie in a theatre!

Of course, you will watch a movie in a theatre!

Rediff.com30 May 2020

Audiences are missing theatres desperately and will go back to them within two-three weeks of them reopening. All those hours of films on television and OTT have not reduced the audience's need for the theatrical experience.

Ramdev summoned in suit by doctors on misinformation against allopathy

Ramdev summoned in suit by doctors on misinformation against allopathy

Rediff.com27 Oct 2021

The Delhi high court on Wednesday issued summons to Ramdev on a lawsuit by several doctors' associations for allegedly spreading misinformation against allopathy amid the COVID-19 pandemic, saying that the plea was not frivolous and a case for its institution was 'definitely' made out.

Govt's new draft rules make it easier to fly drones

Govt's new draft rules make it easier to fly drones

Rediff.com15 Jul 2021

The number of forms to be filled to operate drones in the country have been reduced to six in draft 'Drone Rules, 2021' in comparison to 25 forms mentioned in the Unmanned Aircraft System (UAS) Rules, 2021, it said.

6 Travel Tips For The Perfect Holiday

6 Travel Tips For The Perfect Holiday

Rediff.com22 Nov 2021

To avoid season pricing, keep a close eye on the calendar and begin planning travel at least 60 to 90 days in advance keeping tentative dates in mind.

Oxford COVID-19 vaccine 70% effective, results show

Oxford COVID-19 vaccine 70% effective, results show

Rediff.com23 Nov 2020

However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.

No major side-effects of hydroxychloroquine: ICMR

No major side-effects of hydroxychloroquine: ICMR

Rediff.com26 May 2020

The ICMR's statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns.

US authorizes Pfizer's COVID vaccine for emergency use

US authorizes Pfizer's COVID vaccine for emergency use

Rediff.com12 Dec 2020

According to The New York Times, this move means that many highly vulnerable people will begin receiving the vaccine within days. It further called the authorisation by the FDA as a 'historic turning point' as the US death toll from the Wuhan-originated virus nears 300,000.

Despite the 1962 China scar, Tawang is flourishing

Despite the 1962 China scar, Tawang is flourishing

Rediff.com7 Dec 2021

Tawang wears its history -- and also its present -- with ease. The flourishing town, with restaurants selling everything from noodles to dosas and locals returning home to new business prospects, shows little sign of the tension building up at the border about 40 km away to the north.

Risk of Covid spread from dead bodies unlikely: AIIMS doc

Risk of Covid spread from dead bodies unlikely: AIIMS doc

Rediff.com25 May 2021

Coronavirus doesn't remain active in nasal and oral cavities 12 to 24 hours after the death of an infected person as a result of which the risk of transmission from the deceased is highly unlikely, All India Institute of Medical Sciences Forensic Chief Dr Sudhir Gupta said.

Training of Gaganyaan astronauts in Russia put on hold

Training of Gaganyaan astronauts in Russia put on hold

Rediff.com7 Apr 2020

The four test pilots of the Indian Air Force, chosen for India's manned mission to space, have been undergoing training at the Yu.A. Gagarin Research and Test Cosmonaut Training Centre near Moscow since February.

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Rediff.com12 Sep 2020

AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

India-US coalition begin clinical trials for coronavirus

India-US coalition begin clinical trials for coronavirus

Rediff.com17 Mar 2020

The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.

Mahindra plans to steal the SUV thunder with XUV700

Mahindra plans to steal the SUV thunder with XUV700

Rediff.com18 Aug 2021

A new XUV, a new logo, and a big bang at the launch! Mahindra revealed its keenly-awaited XUV700 in Chennai on Saturday.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

China aggressively trying to hack Indian cyberspace

China aggressively trying to hack Indian cyberspace

Rediff.com3 Mar 2021

Experts said attempts from China have increased in the last year, which further amplified after the Indian government banned Chinese applications post the Galwan clash.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

India has 'best' Covid recovery rate, lowest mortality: Harsh Vardhan

India has 'best' Covid recovery rate, lowest mortality: Harsh Vardhan

Rediff.com22 Aug 2020

After inaugurating a 10-bed make-shift hospital of the National Disaster Response Force (NDRF) in Ghaziabad near Delhi, he said India began formulating its strategy against coronavirus from January 8 as soon as the world came to know about the outbreak of the disease.

Railways rolls out economy AC 3-tier train coach

Railways rolls out economy AC 3-tier train coach

Rediff.com12 Feb 2021

These coaches, officials said, will be "economical" and in between the current AC three-tier and non-AC sleeper class.

IPL will have two-and-half month window in next FTP: Shah

IPL will have two-and-half month window in next FTP: Shah

Rediff.com14 Jun 2022

BCCI secretary Jay Shah spoke on a range of subjects related to Indian cricket, IPL's place in the global cricket calendar, running the cricket establishment in times of COVID-19 and the road ahead for both Indian cricket and IPL.

'Don't deserve this': Bharat Biotech hits outs at critics

'Don't deserve this': Bharat Biotech hits outs at critics

Rediff.com4 Jan 2021

He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Rediff.com24 May 2021

This design serves two purposes -- first, keeps the health workers well-ventilated, while preventing bodily discomfort, and second, keeps them safe from various fungal infections.

'IPL in UAE is much-needed chaos we need in our lives'

'IPL in UAE is much-needed chaos we need in our lives'

Rediff.com18 Aug 2020

Ravi Shastri said that UAE in 2014 had shown that it is well capable of handling a tournament of this magnitude.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

Pfizer Covid vaccine gets US experts' nod

Pfizer Covid vaccine gets US experts' nod

Rediff.com11 Dec 2020

The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.

Zoos across India on 'highest' alert after tiger in US gets COVID-19

Zoos across India on 'highest' alert after tiger in US gets COVID-19

Rediff.com7 Apr 2020

The female tiger, named Nadia, is believed to be the first known case of an animal infected with COVID-19 in the US. It is suspected that she contracted the virus from a caretaker who was asymptomatic at that time.

'Indian kids are the most cyber-bullied'

'Indian kids are the most cyber-bullied'

Rediff.com24 Feb 2022

At 13, Anoushka Jolly has received funding for her app Kavach through which students like her can report incidents of bullying and harassment anonymously

6 feet apart may not be enough to stop COVID-19

6 feet apart may not be enough to stop COVID-19

Rediff.com20 May 2020

According to the scientists, shorter adults and children could be at higher risk if they are located within the trajectory of the saliva droplets.

'Deadline for COVID-19 vaccine unfeasible, unrealistic'

'Deadline for COVID-19 vaccine unfeasible, unrealistic'

Rediff.com6 Jul 2020

'The Indian Academy of Sciences, strongly believes that any hasty solution that may compromise rigorous scientific processes and standards will likely have long-term adverse impacts of unforeseen magnitude on citizens of India'

Hot Buys: IT, FMCG, auto, metal stocks

Hot Buys: IT, FMCG, auto, metal stocks

Rediff.com4 May 2018

The surge in IT, auto and FMCG stocks were led by investors seeking safety against market volatility.

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

COVID effect: No motorcycle stunts at R-Day parade this year

COVID effect: No motorcycle stunts at R-Day parade this year

Rediff.com23 Jan 2021

The spectator size too has been reduced to 25,000, officials said.

Elite athletes at risk of coronavirus spread to lungs

Elite athletes at risk of coronavirus spread to lungs

Rediff.com29 Apr 2020

The research suggests that due to strenuous exercise, elite athletes are more likely to inhale virus particles and direct them to the lower areas of the lung.

China probed weaponising COVID in 2015: Reports

China probed weaponising COVID in 2015: Reports

Rediff.com10 May 2021

The paper also includes musing that SARS -- which hit China in 2003 -- could have been a man-made bioweapon deliberately unleashed by "terrorists".

Man who warned of the Bhopal gas leak

Man who warned of the Bhopal gas leak

Rediff.com22 May 2021

Just months before the deadly gas leak in Bhopal killed 15,000 people, journalist Rajkumar Keswani -- who passed into the ages on Friday, May 21, 2021 -- had warned that the 'city stood on the edge of a volcano'.

Indian equities may lose sheen on lofty valuations: Analysts

Indian equities may lose sheen on lofty valuations: Analysts

Rediff.com3 Sep 2021

Bulls might be on the rampage on Dalal Street but lofty valuations of the Indian equities present a reason for concern and the markets could perhaps witness up to 10 per cent correction, according to analysts. Benchmark indices have been on a record-breaking rally lately and August witnessed the stock market reaching many new highs. The BSE benchmark soared over 9 per cent last month.